Adverse Event Reporting—New FDA Report Puts Things in Perspective

Research published in the October 2008 issue of Pediatrics says that some of free prescription drug samples being distributed to pediatric patients may be unsafe. The researchers found that one in twenty American children received free drug samples in 2004—and that the most frequently distributed samples were unsafe to children. Four of the 15 most […]

Read More

Under the Influence — Doctors and Prescription Drug Firms

Today’s news, both political and financial, is filled with tales of greed and corruption. Vested interests ensure that earmarks litter important legislation. The lust for a quick profit and lax regulation have led to bank closures. Wall Street and Capitol Hill are now awash in finger-pointing by consumers whose investments are worth a fraction of […]

Read More

Chelation TACT Trial Announces that Enrollment Has Temporarily Ceased

The investigators and institutions that have been participating in the National Institutes of Health Trial to Assess Chelation Therapy (TACT) have temporarily and voluntarily suspended enrollment of new participants in the study. The lead TACT investigator, Gervasio Lamas, M.D., of the University of Miami’s Miller School of Medicine, received a complaint from an outside party […]

Read More